Heska Corporation announced that Dr. Michael McGinley, the company’s President, Biologicals & Pharmaceuticals, amicably agreed to terminate his employment as an involuntary termination effective March 31, 2018 (the “Separation Date”), under a Separation Agreement and Release, dated as of December 23, 2017, pursuant to which (i) Dr. McGinley agreed, among other things, to continue providing services to the company through the Separation Date, to execute a customary release of claims in favor of the company, and to refrain from engaging in certain competitive conduct against the company for 36 months after the Separation Date.